Psychiatry Advisor Content Writers

Researchers suggest the Narcolepsy Severity Scale be used more frequently in the clinical settings and future narcolepsy studies.

Telephone-based motivational interviewing may improve a patient’s rate of initiating behavioral therapy for treatment of migraine.

The researchers concluded that patients with both MS and depression experience worsening in neurological function, relapses, and lesions activity after 1 year compared with patients without depression.

The study compared improvements in frontal lobe dysfunction induced by rTMS and improvement of white matter integrity revealed by diffusion tensor imaging in patients with TRD receiving rTMS treatment.

Researchers found data that showed differences in retinal microvascular diameters in patients with schizophrenia and bipolar disorder when compared with healthy participants, which researchers believe shows that retinal vascular abnormalities are indicative of cerebral vascular abnormalities.

The Brief Negative Symptom Scale (BNSS) is internally consistent and validated for the assessment of negative symptoms in patients with schizophrenia, according to a study published in Schizophrenia Research. The investigators of this study sought to examine the reliability, validity, and factor structure of the BNSS in an Asian population, as well as to explore the…

Researchers of a small cohort of patients with schizophrenia discovered that using the CrossCheck behavioral sensing system to remotely monitor participants’ smartphones provided insight into social behavior with results showing that a decrease in outgoing text messages and phone calls indicated a potential relapse.

Researchers found data from an aerobic exercise study at the University Medical Center Göttingen in Germany, which showed that in those with schizophrenia and also having chronotropic incompetence aerobic fitness interventions were ineffective for improvement in either condition.

Results showed that most common NSAIDs, including aspirin, ibuprofen, naproxen, and celecoxib, did not alter cognitive degeneration in patients with mild cognitive impairment or Alzheimer disease.

The Maudsley Staging Method may be a valuable tool for quantifying treatment-resistant depression.